Stocks of MetLife - Current price, Where to buy? Dividends
| Detail | Data |
|---|---|
| Stocks: | MetLife |
| ompany Name: | MetLife, Inc. |
| Ticker: | MET |
| Exchange: | NYSE |
| Outstanding stocks: | 713,118,976 |
| 24-hour Volume: | 5,197,760 |
| Industry: | Insurance - Life |
| Sector: | Financial Services |
| Number of Employees: | 45000 |
| Country: | United States |
| City: | New York |
| Address: | 200 Park Avenue |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 38.91 | 7.08 | 1.81 USD | 9.95 USD | 41.07 USD | 50,289,147,904.00 USD |
| P/E Ratio: | 38.91 |
|---|---|
| Forward P/E: | 7.08 |
| EPS: | 1.81 USD |
| Forward EPS: | 9.95 |
| Book value per share: | 41.07 USD |
| Market capitalization: | 50,289,147,904.00 USD |
MetLife
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 66,901,000,192.00 USD |
| Net Income: | 1,380,000,000.00 USD |
| Price-to-Book (P/B) Ratio: | 1.71 |
| PEG Ratio: | / |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for MetLife stocks is: none |
| Number of Analysts: | MetLife stocks are not covered by analysts. |
| Highest Target Price: | / |
| Lowest Target Price: | / |
| Average Target Price: | / |
Note: The data is approximate. Recommendations and price forecasts for MetLife stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | Company MetLife pays a dividend of 2.18 USD per share. |
| Annual Yield %: | 3.1 % |
| Ex-dividend Date: | 2024-05-06 |
| Average % Yield for 5 Years: | 3.45 % |
| Payout Ratio: | 113.81 % |
| Value of Last Dividend Paid: | 0.52 USD |
| Date of Last Dividend: | 2024-02-05 |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy MetLife Stocks?
If you're interested in investing in MetLife stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of MetLife stocks through mobile apps with client support. In this table, you can compare brokers offering real MetLife stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about MetLife (MET)
MetLife consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 66,901,000,192.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 3,919,000,064.00 USD, MetLife maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. A higher debt-to-equity ratio of 1.64 indicates higher leverage for MetLife compared to its equity, requiring cautious management. Gross margin of 22.22% indicates room for MetLife to improve cost efficiency and competitiveness. Lower profit margin of 2.36% suggests opportunities for MetLife to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 66,901,000,192.00 USD |
| EBITDA: | 3,919,000,064.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 1.81 USD |
| Book Value Per Share: | 41.07 USD |
| Total Cash: | 30,358,999,040.00 USD |
| Total Cash per Share: | 41.99 USD |
| Total Debt: | 49,704,001,536.00 USD |
| Debt to Equity Ratio: | 1.64 |
| Quick Ratio: | 1.30 |
| Current Ratio: | 1.54 |
| Free Cash Flow: | -7,448,500,224.00 USD |
| Operating Cash Flow: | 13,720,999,936.00 USD |
| Company Margins | |
| Gross Margins: | 22.22 % |
| EBITDA Margins: | 5.86 % |
| Operating Margins: | 13.83 % |
| Profit Margins: | 2.36 % |
| Performance | |
| Return on Assets: | 0.3 % |
| Return on Equity: | 5.3 % |
| Earnings Growth (1 year): | -60.7% |
| Revenue Growth (1 year): | 21.9 % |
| Year-over-Year Quarterly Earnings Growth: | -61.5 % |
| Valuation | |
| Market Capitalization: | 50,289,147,904.00 USD |
| Enterprise Value: | 70,498,091,008.00 USD |
| EV/Revenue: | 1.054 |
| EV/EBITDA: | 17.989 |
| Number of Shares and Short Shares | |
| Float Shares: | 603,714,731 shares |
| Shares Outstanding: | 723,020,032 shares |
| Held Percent Insiders: | 0.16 % |
| Held Percent Institutions: | 75.98 % |
| Shares Short: | 7,435,090 |
| Shares Short Prior Month: | 7,145,377 |
| Date Short Interest: | 2024-04-15 |
| Shares Percent Shares Out: | 1.03 % |
| Short Ratio: | 2.63 |
| Beta: | 1.03 |
| Short Percent of Float: | 1.24 % |
| Předpokládaný počet akcií: | 723,020,032 |
Frequently Asked Questions (FAQ)
The company MetLife pays a dividend of 2.18 USD per share. At this rate, the annual yield is 3.10 %.
MetLife shares are traded on the stock exchange NYSE under the ticker symbol: MET. You can buy or trade them with a variety of stock brokers offering real stock trading services.
There has been no prediction or recommendation issued for MetLife shares yet.
The total number of MetLife shares on the exchange is 723,020,032.00, which, at the current market capitalization, values the company at 50,289,147,904.00 USD.
